Autocrine regulation of ICAM-1 expression on bladder cancer cell lines: evidence for the role of IL-1α
- 1 May 1994
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 40 (2) , 117-124
- https://doi.org/10.1016/0165-2478(94)90182-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Expression and shedding of ICAM‐1 in bladder cancer and its immunotherapyInternational Journal of Cancer, 1993
- Cytokine-induced tumor immunogenicity: endogenous interleukin-1α expressed by fibrosarcoma cells confers reduced tumorigenicityImmunology Letters, 1993
- Costimulation via Vascular Cell Adhesion Molecule-1 Induces in T Cells Increased Responsiveness to the CD28 Counter-receptor B7Cellular Immunology, 1993
- The immunomodulatory effects of urine from patients with superficial bladder cancer receiving intravesical evans BCG therapyCancer Immunology, Immunotherapy, 1993
- Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4.The Journal of Immunology, 1992
- Regulation by retinoic acid of ICAM-1 expression on human tumor cell linesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1991
- A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM-1) modulates the release of tumor necrosis factor-α, interferon-γ and interleukin 1European Journal of Immunology, 1990
- In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts.The Journal of Immunology, 1990
- CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSESAnnual Review of Biochemistry, 1990
- Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist proteinNature, 1990